Increased adiposity does not exacerbate impaired vasodilation in rats exposed to eucapnic intermittent hypoxia.
Increased adiposity does not exacerbate impaired vasodilation in rats exposed to eucapnic intermittent hypoxia.
复制标题
暴露于常碳酸间歇性缺氧的大鼠中,肥胖增加不会加剧血管舒张受损。
DOI:
10.1159/000320322
复制
发表时间:
2011
期刊:
影响因子:
--
通讯作者:
Walker,BenjimenR
中科院分区:
文献类型:
--
作者:
Sweazea,KarenL;Kanagy,NancyL;Walker,BenjimenR
BackgroundAlthough there often is a clinical co-incidence of increased adiposity and obstructive sleep apnea, each factor is independently associated with elevated oxidative stress.ObjectiveWe hypothesized that overweight rats exposed to simulated sleep apnea would develop exacerbated oxidative stress leading to impaired endothelium-dependent vasodilation.MethodsRats were fed either a chow or high-fat diet (HFD; 60% kcal from fat) for 6 weeks. During the final 14 days of each diet, animals were exposed to either air or eucapnic intermittent hypoxia (E-IH) to simulate sleep apnea.ResultsRats exposed to either E-IH or HFD alone showed increases of 161 and 176%, respectively, in oxidative stress (measured as thiobarbituric acid-reactive substances) compared to chow+ air controls. However, oxidative stress was lower following combined HFD+ E-IH treatment (132% of chow+ air controls) compared to each individual treatment. All three treatment groups, chow+ E-IH, HFD+ air and HFD+ E-IH, had increased blood pressure (144.5±4.4, 148.2±5.6, and 136.2±2.0 mm Hg, respectively, vs. chow+ air: 123±2.0 mm Hg) and attenuated acetylcholine (ACh)-mediated vasodilation (78.3, 72.7, and 78.2% of the chow+ air response at the highest dose of ACh) compared to chow+ air controls. Combined HFD and E-IH treatment did not further impair vasodilation compared to chow+ E-IH alone. Vasodilatory responses were normalized by the antioxidant EUK-134 in each treatment group.ConclusionsIncreased adiposity and simulated sleep apnea impair endothelium-dependent vasodilation through enhanced generation of reactive oxygen species (ROS). However, the combined treatment does not exacerbate either ROS generation or vascular dysfunction observed with HFD or E-IH alone.